Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1270-1271 (29 May), doi:10.1136/bmj.328.7451.1270
Data at the individual level are needed to direct policies
| The first 150 words of the full text of this article appear below. |
Concern exists worldwide about the threat posed to human health by antibiotic resistance in common microbial pathogens. In response the World Health Organization has launched a global strategy for containment of antimicrobial resistance and the United Kingdom has an antimicrobial resistance strategy and action plan.1 2 Fundamental to any action is an accurate understanding of the relation between prescribing and resistance. This is especially important where most prescribing occursin the community.
At the level of individual patients a link between prescribing and resistance has been found for many bacteria.3 In the United Kingdom, data about antibiotic prescribing are usually available only at the practice level. These have been investigated in relation to bacterial resistance to antibiotics, with only a weak association found.4 The validity of such analysis can be questioned, however, because exposure and outcome in any one individual are not linked and controls are not available. These potential flaws can
Mark Woodhead, consultant in general and respiratory medicine
Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester M13 9WL (mark.woodhead@cmmc.nhs.uk)
Douglas Fleming, director
Research Unit, Royal College of General Practitioners, Birmingham B17 9DB
Richard Wise, professor
Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH
Read all Rapid Responses